Literature DB >> 1886490

Comparison of serological and chemical characteristics of capsular polysaccharides of Cryptococcus neoformans var. neoformans serotype A and Cryptococcus albidus var. albidus.

R Ikeda1, H Matsuyama, A Nishikawa, T Shinoda, Y Fukazawa.   

Abstract

The antigenic formula and chemical structure of capsular polysaccharide (CPS) of Cryptococcus albidus var. albidus (C. albidus) were studied in relation to those of C. neoformans var. neoformans serotype A (C. neoformans A). The results of slide agglutination tests with factor sera and reciprocal adsorption experiments showed that antigenic formula of C. albidus was the same as that of C. neoformans A. The soluble CPSs from the two species were obtained from culture supernatants by precipitation with ethanol followed by purification by chromatography on DEAE-cellulose column. The structural analyses of such CPSs from the two species showed that the antigenic CPS fractions consisted of a backbone of alpha(1-3)-linked D-mannopyranosyl residues with a single branch of beta(1-2)-xylose or glucuronic acid, and mostly with O-acetyl groups, in which side chains and O-acetyl groups were responsible for antigenic specificity. It was found that there was a minor difference between the CPS of C. neoformans A and that of C. albidus; in the former, unsubstituted mannose residues existed in a low frequency, but in the latter none. Moreover, the 1H-nuclear magnetic resonance spectra of partially hydrolyzed acidic fragments of the two CPSs indicated that two xylose side chains were present between glucuronic acid side chains. Taken together, it was suggested that these two species of C. neoformans A and C. albidus are closely related to each other in their CPSs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1886490     DOI: 10.1111/j.1348-0421.1991.tb01540.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  5 in total

1.  Monoclonal antibody 13F1 produces annular immunofluorescence patterns on Cryptococcus neoformans serotype AD isolates.

Authors:  W Cleare; M E Brandt; A Casadevall
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Production of agglutinating monoclonal antibody against antigen 8 specific for Cryptococcus neoformans serotype D.

Authors:  R Ikeda; S Nishimura; A Nishikawa; T Shinoda
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

3.  Exploring Cryptococcus neoformans capsule structure and assembly with a hydroxylamine-armed fluorescent probe.

Authors:  Conor J Crawford; Radamés J B Cordero; Lorenzo Guazzelli; Maggie P Wear; Anthony Bowen; Stefan Oscarson; Arturo Casadevall
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

4.  Laccase and melanization in clinically important Cryptococcus species other than Cryptococcus neoformans.

Authors:  Reiko Ikeda; Takashi Sugita; Eric S Jacobson; Takako Shinoda
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

5.  Interaction of surface molecules on Cryptococcus neoformans with plasminogen.

Authors:  Reiko Ikeda; Tomoe Ichikawa
Journal:  FEMS Yeast Res       Date:  2014-01-13       Impact factor: 2.796

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.